Rapid transcriptional responses to serum exposure are associated with sensitivity and resistance to antibody-mediated complement killing in invasive; Salmonella; Typhimurium ST313 by Ondari, Edna M. et al.
 Open Peer Review
RESEARCH ARTICLE
Rapid transcriptional responses to serum exposure are
associated with sensitivity and resistance to antibody-mediated
 complement killing in invasive  Typhimurium ST313Salmonella
[version 1; peer review: 2 approved]
Edna M. Ondari ,     Elizabeth J. Klemm , Chisomo L. Msefula ,
     Moataz Abd El Ghany , Jennifer N. Heath , Derek J. Pickard ,
     Lars Barquist , Gordon Dougan , Robert A. Kingsley ,
Calman A. MacLennan9,14*
Swiss Tropical and Public Health Institute, University of Basel, Basel, Switzerland
University of Basel, Basel, Switzerland
Novartis Vaccines Institute for Global Health, Siena, Italy
Wellcome Trust Sanger Institute, Hinxton, UK
Malawi-Liverpool-Wellcome Trust Clinical Research Institute, Blantyre, Malawi
Department of Microbiology, College of Medicine, University of Malawi, Blantyre, Malawi
The Westmead Institute for Medical Research and Marie Bashir Institute for Infectious Diseases and Biosecurity, University of Sydney,
Westmead, Australia
King Abdullah University of Science and Technology , Thuwal, Saudi Arabia
Institute of Immunology and Immuotherapy, University of Birmingham, Birmingham, UK
Helmholtz Institute for RNA-based Infection Research , Würzburg, Germany
Faculty of Medicine, University of Würzburg, Würzburg, Germany
Department of Medicine, University of Cambridge Addenbrooke's Hospital Cambridge, Cambridge, UK
Quadram Institute Bioscience, Norwich, UK
Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK
 Equal contributors
Abstract
:   Typhimurium ST313 exhibits signatures ofBackground Salmonella
adaptation to invasive human infection, including higher resistance to
humoral immune responses than gastrointestinal isolates. Full resistance to
antibody-mediated complement killing (serum resistance) among
nontyphoidal   is uncommon, but selection of highly resistantSalmonellae
strains could compromise vaccine-induced antibody immunity. Here, we
address the hypothesis that serum resistance is due to a distinct genotype
or transcriptome response in  . Typhimurium ST313.S
: Six  . Typhimurium ST313 bloodstream isolates, three of whichMethods S
were antibody resistant, were studied. Genomic content (single nucleotide
polymorphisms and larger chromosomal modifications) of the strains was
determined by Illumina and PACBIO sequencing, and functionally
1-4 4 4-6
4,7,8 9 4
4,10,11 4,12 13*
1
2
3
4
5
6
7
8
9
10
11
12
13
14
*
   Reviewer Status
  Invited Reviewers
 version 1
published
25 Apr 2019
 1 2
report report
, University of CaliforniaManuela Raffatellu
San Diego, La Jolla, USA
1
 25 Apr 2019,  :74 (First published: 4
)https://doi.org/10.12688/wellcomeopenres.15059.1
 25 Apr 2019,  :74 (Latest published: 4
)https://doi.org/10.12688/wellcomeopenres.15059.1
v1
Page 1 of 16
Wellcome Open Research 2019, 4:74 Last updated: 10 JUN 2019
 Any reports and responses or comments on the
article can be found at the end of the article.
determined by Illumina and PACBIO sequencing, and functionally
characterized using RNA-seq, transposon directed insertion site
sequencing (TraDIS), targeted gene deletion and transfer of selected point
mutations in an attempt to identify features associated with serum
resistance.
  : Sequence polymorphisms in genes from strains with atypicalResults
serum susceptibility when transferred from strains that were highly resistant
or susceptible to a strain that exhibited intermediate susceptibility did not
significantly alter serum killing phenotype. No large chromosomal
modifications typified serum resistance or susceptibility. Genes required for
resistance to serum identified by TraDIS and RNA-seq included those
involved in exopolysaccharide synthesis, iron scavenging and metabolism.
Most of the down-regulated genes were associated with membrane
proteins. Resistant and susceptible strains had distinct transcriptional
responses to serum, particularly related to genes responsible for
polysaccharide biosynthesis. There was higher upregulation of   locuswca
genes, involved in the biosynthesis of colanic acid exopolysaccharide, in
susceptible strains and increased expression of  , a regulator of veryfepE
long-chain lipopolysaccharide in resistant strains.
: Clinical isolates of  . Typhimurium ST313 exhibit distinctConclusion S
antibody susceptibility phenotypes that may be associated with changes in
gene expression on exposure to serum.
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Introduction
Invasive nontyphoidal Salmonella (iNTS) infections are 
estimated to cause ~3.4 million illnesses and over 680,000 
deaths annually1, with a majority of these cases occurring in 
sub-Saharan Africa1,2. Predisposing factors include co-morbidities 
such as malaria3–6, HIV co-infection7–9, young age10,11, and 
malnutrition12–14. A clonal genotype of Salmonella enterica 
serovar Typhimurium (S. Typhimurium) of sequence type 313 
(ST313)15, dominates iNTS disease in sub-Saharan Africa and 
this clone frequently encodes multiple drug resistance16–21. These 
factors likely contribute to the relatively high prevalence of 
invasive disease in the region compared to that observed with 
nontyphoidal Salmonella in other parts of the world, where 
gastroenteritis dominates.
A prominent signature in the genomes S. Typhimurium ST313 
isolates is genetic degradation, associated with gene deletion 
and the accumulation of pseudogenes, resembling that observed 
in host-restricted Salmonella serovars such as S. Typhi, the 
causative agent of typhoid fever15. Nevertheless, the ST313 found 
in Africa are monophyletic, falling into two highly conserved 
clades known as clades or lineages I and II15. Phenotypically, 
ST313 isolates of both clades broadly exhibit decreased 
enteropathogenicity16,22, hyper-dissemination from the intestine23, 
hyper-resistance to phagocytic killing24 and complement20,25, 
and altered multicellular behaviour17.
The predilection for invasive disease exhibited by ST313 
underscores an important role for an effective humoral response 
to NTS during extra-intestinal infection11,26. Antibodies 
mediate opsonisation and killing by phagocytic cells26, and 
direct bacterial killing by complement during inter-macrophage 
spread11. Vaccines eliciting these responses, therefore, are a 
potentially promising means of protecting individuals from 
developing iNTS disease.
Multiple, and possibly redundant mechanisms for evading 
antibody responses have been described for Salmonella. These 
include survival in phagocytes associated with virulence 
factors such as Salmonella Pathognicity Island (SPI-2)27, and 
the production of proteins that actively degrade or inhibit 
complement proteins such as PgtE28,29, Rck30, PagC31. and 
TraT32. Recently, a SNP was identified in the promoter of pgtE 
resulting in high expression of the PgtE virulence factor in 
lineage II African ST313 S. Typhimurium. PgtE increases 
degradation of factor B component of human complement, 
likely contributing to serum resistance of the ST313 pathovar of 
S. Typhimurium20.
Lipopolysaccharide (LPS) O-antigen length and composition 
can also play a key role in bacterial survival during bloodstream 
infection, by shielding bacteria against direct complement 
attack and killing by blood phagocytes33–35. Subunit vaccines 
that can induce antibodies capable of directing complement-
mediated killing are under development for the prevention 
of iNTS disease in sub-Saharan Africa36–40. The presence of 
variants that evade antibody-mediated killing conferred by a 
vaccine could undermine this strategy. Here we address the 
hypothesis that variation in genotype or transcriptional response 
to serum of clinical isolates of iNTS correlates with serum 
susceptibility.
Methods
Bacteria and culture conditions. Six S. Typhimurium from a 
series of 329 iNTS isolates from bacteraemic children admit-
ted to Queen Elizabeth Central Hospital, Blantyre, Malawi with 
defined susceptibility to complement-mediated bactericidal activ-
ity were used in this study. Bacteria were routinely maintained in 
normal (10 g/l) or low salt (5 g/l) Luria-Bertani broth (Invitrogen, 
catalogue numbers 12795027 and 12780052 respectively) and 
grown aerobically at 37°C. Where appropriate, derivative mutant 
strains were grown in LB media supplemented with 100 µg/ml 
of hygromycin, or 50 µg/ml of kanamycin (Sigma-Aldrich, 
catalogue numbers 10687010 and 11815032 respectively).
Investigation of the stability of the serum susceptibility 
phenotype. Suspensions of two isolates, D23005 (serum resist-
ant) and D24545 (highly serum sensitive) were spread on Luria- 
Bertani (LB) agar plates at a density of approximately 500 cfu 
and grown overnight. 100 colonies of each isolate were then 
grown to log phase in LB broth and exposed to serum for 
three hours. Serum susceptibility phenotype was then determined 
using serum bactericidal assays (described below).
Identification of single nucleotide polymorphisms. Sequence 
read alignment and detection of single nucleotide polymorphisms 
(SNP’s) were performed using paired-end Illumina sequence 
data mapped to the reference genomes S. Typhimurium D23580 
and SL1344 with SMALT. SNPs were identified using samtools 
mpileup v0.2.0 and filtered with a minimum mapping quality 
of 30 and quality ratio cut-off of 0.75.
Transfer of point mutations by transduction. Nonsynony-
mous polymorphisms were transferred into S. Typhimurium 
D23580 by co-transduction with a selectable marker. A kanamycin 
resistance cassette was inserted into intergenic regions within 
1kb of each selected point mutation in the donor strains by 
homologous recombination as described previously41, using 
primers designed to avoid disrupting gene promoters (Table S1, 
Extended data42). Phage P22 lysates of the resulting deriva-
tive strains were then used to infect D23580, using the kan-
amycin marker to select for transductants. Colonies were 
screened for the transfer of the desired allele using specific 
PCR oligonucleotide primers (Table S1, Extended data42) and 
confirmed by sequencing.
Serum bactericidal assays. Normal human serum was obtained 
from the blood of a healthy adult donor. Clotting was performed 
at room temperature within two hours of the blood draw. Serum 
was then separated from the clotted fraction by centrifugation 
and stored in aliquots at -80°C until use. Test S. Typhimurium 
strains were grown to mid-log phase by inoculating 100-fold 
dilutions of overnight cultures into fresh LB broth and grown 
aerobically for 135 minutes at 37°C. The bacteria were then 
washed twice with phosphate-buffered saline (PBS), and approxi-
mately 1×106 cfu/ml were incubated with serum for 3 hours at 
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37°C. Serum susceptibility was determined by the change in 
numbers of viable bacteria after 3 hours of serum exposure, using 
serial dilutions of the serum-bacteria mixtures plated on LB 
agar.
Transposon mutant library construction and screening. 
A derivative of the transposon EZ-Tn5 (Epicentre, Catalogue 
number MOD1503) was phosphorylated with polynucleotide 
kinase (New England BioLabs Inc.), and incubated with 
EZ-Tn5 transposases (Epicentre, catalogue number TNP92110) 
at 37°C for 1 hour to prepare the transposome, which was 
stored at -20ºC until ready for use. D23580 electrocompetent 
cells were mixed with 0.5 µL of transposomes and transformed 
by electroporation in a 0.2 cm cuvette (Bio-Rad Laboratories) 
using parameters (2.5 kV, 25 F and 200 Ω) in Gene Pulser Xcell 
Electroporation System (Bio-Rad Laboratories). Cells were 
immediately re-suspended in 1 mL of SOC medium (Invitro-
gen, catalogue number 1554034) and incubated at 37°C for 2 hr 
before being spread on LB agar supplemented with kanamycin 
(10 µg/mL). The D23580 library consisted of 6×105 mutants. 
Stationary phase cultures were then prepared by 1/200 dilution 
of mutant library in LB broth, vortexed briefly, and incubated 
aerobically at 37°C overnight with shaking. Log phase cultures 
(input library) were then prepared by 1/100 dilution of the 
overnight culture in LB broth and 2.5 hours of incubation at 37°C 
(without venting), on a rocker plate at 20 rev/sec. Viable counts 
of the input library were determined by serial dilution in PBS 
and plating of a sample of the neat input culture. An aliquot of 
the input library was harvested by centrifugation at 6000 rpm for 
5 minutes. The supernatant was decanted, and the pellet washed 
three times in PBS (pH 7.4), then resuspended in PBS to a final 
concentration of 1×108/ml bacteria. Serum bactericidal assays 
were performed as described above but using pooled serum 
from 10 healthy Malawian adults. After 180 minutes, the entire 
serum-bacteria suspension was transferred to 25 ml LB broth, 
vortexed and incubated overnight aerobically 37°C, to enable 
the surviving library to outgrow killed components. Viable 
counts were determined from the output library, and the remain-
ing output culture pelleted at 6000 rpm for 20 minutes at 4°C, 
the supernatant removed, and frozen at -80°C until ready for use.
Transposon directed insertion site sequencing (TraDIS). 
Genomic DNA (gDNA) of the initial (input) and selected 
(output) mutant pools was extracted using Qiagen Genomic-tip 
100/G (Qiagen, Hiden, Germany, catalogue number 10043). 
Approximately 2µg of gDNA was fragmented to insert size 
of ~300 bp using E220 Evolution Somicator (Covaris). The 
fragmented DNA was end repaired, A-tailed and adapter- 
ligated using Illumina DNA fragment library preparation kit 
(New England BioLabs Inc., catalogue number E6177) accord-
ing to the manufacturer’s instructions. The libraries were then 
enriched by 10-20 PCR cycles using a transposon-specific 
forward primer and a reverse primer that included Illumina 
flow cell binding sites as described previously43. The enriched 
libraries were purified using the Agen court AMPure XP beads 
(Beckman Coulter, catalogue number A63882) and quantified 
on an Agilent DNA1000 chip (Agilent Technologies, Catalogue 
number 5067-1504) as per the manufacturer’s instructions. The 
libraries were sequenced on a HiSeq2000 Illumina platform as 
single-end reads of 100bp. The reads were processed using the 
Bio::TraDIS toolkit v1.13219044. Briefly, reads were filtered 
for 10 bases matching the expected transposon tag sequence. 
Filtered reads were then mapped against D23580 reference 
genome (GenBank accession number FN424405) using SMALT 
version 0.7.2, and transposon insertion sites and insertion 
indices (obtained by dividing the number of unique insertion sites 
by the gene length) were determined for every gene. Genes with 
read counts of less than 20 in all conditions were excluded from 
the analysis. Log2 fold changes and significance of changes in 
mutant abundance before (input; the basic mutant pool) and after 
selection (output; biological replicates of mutant pool screened 
in the presence of bactericidal serum) were calculated using 
edgeR v3.4.0 after normalization using TMM method45.
Targeted gene deletion in D23580. Deletion of genes in 
S. Typhimurium D23580 was performed by recombinase- 
mediated allelic exchange as described previously41. PCR frag-
ments were made by amplifying the kanamycin resistance gene 
from plasmid pKD4, with each primer consisting of 50-mer 
homology arms flanking each targeted gene such that the entire 
open reading frame was deleted, and 20 nucleotides priming 
pKD4 at the 3’ends (primers in Table S1, Extended data42). A 
second round of PCR using gel-purified products from the first 
reactions as templates was performed to eliminate pKD4 from 
the material used for electroporation. Recombinase-proficient 
D23580 bacteria harbouring the pSIM18 helper plasmid 
were transformed using approximately 1 µg of PCR product. 
Transformants were then selected on LB plates with kanamy-
cin, and the gene replacement verified by screening colonies 
using PCR from extracted genomic DNA and primers specified 
in Table S1 (Extended data42). Culture of transformants at 42°C 
(non-permissive temperature for pSIM18 replication), and 
isolation of kanamycin resistant and hygromycin sensitive 
colonies by replica plating was used to cure and verify loss of 
pSIM18.
PacBio sequencing and assembly. To prepare high molecular 
weight genomic DNA, log-phase cultures of each strain were 
prepared in 10 ml of LB broth as described above. Each culture 
was then centrifuged and the pellets resuspended in 2 ml of 25% 
(w/v) sucrose in TE buffer (10 mM Tris, 1 mM EDTA, pH 8.0). 
5 mg of lysozyme (Roche, catalogue number 10837059001) 
was then added to each suspension, and incubated for 
45 minutes at 37°C. 2 mg of proteinase K (Roche, catalogue 
number P4850), 300 µg of RNase A (Roche, catalogue number 
10109169001), EDTA (pH 8.0) at a final concentration of 0.02 
M, and 250 µl of 10% Sarkosyl NL30 (BDH/Fisher, catalogue 
number BP234-500) were added to the suspensions, then left 
on ice for 2 hours. Lysates were placed on a 50°C block 
overnight, then reconstituted to 5 ml using TE buffer. Samples 
were mixed with an equal volume of phenol:chloroform:isoamyl 
alcohol (25:24:1) in 15 ml phase-lock gel tubes (Eppendorf, 
catalogue number 0032005250), centrifuged for 15 minutes at 
4000rpm, and the aqueous phases transferred to a fresh tube, 
and repeated three times. The aqueous phase was mixed with 
2.5 volumes of 100% ethanol and incubated at -20°C for 1 hour 
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to precipitate the DNA. The DNA was separated from the ethanol 
by centrifugation, washed with 70% ethanol, resuspended in TE 
buffer, and stored at -80°C until use.
PacBio sequencing was performed on a PacBio RS sequencer. 
Sequence reads were assembled using HGAP v346 of the SMRT-
Analysis software v2.3.047. Sequence coverage for picking the 
minimum fragment length for assembly was set to 30, and the 
approximate genome size was set to 3 Mbp. The assembly was 
circularized using the pre-assembled reads in Circlator v1.1.348. 
The circularized assembly was then improved using the PacBio 
RS_Resequencing protocol and Quiver v1 of the SMRT analysis 
software v2.3.047.
RNA sequence analysis. Log-phase (OD600 0.2, determined using 
an Ultrospec 10 spectrophotometer, Amersham Biosciences) 
cultures of each strain were prepared in 10 ml of LB broth as 
described previously. Bacteria were resuspended to an OD600 of 
2.0. 100 µl of this suspension was then inoculated into 900 µl of 
LB and 900 µl of normal human serum (to a final concentration of 
approximately108 cfu/ml) in 2ml microcentrifuge tubes. The 
tubes were incubated in a horizontal position with shaking 
at 60rpm at 37°C for 10 minutes, after which the bacteria were 
pelleted by centrifuging at 13000 rpm for 2 minutes, and the 
media/serum discarded. The pellets were resuspended in 1ml 
of ice-cold PBS. RNA was immediately stabilized as described 
previously49, by adding 400µl (20%v/v) of a cold mixture of 
100% ethanol and phenol saturated with 0.1 M citrate buffer 
at pH 4.3 (Sigma, catalogue number P4862) (19:1 v/v) to each 
sample and incubating on ice for 30 minutes. Extractions were 
performed using the FastRNA Pro Blue Kit (MP Biomedicals, 
catalogue number 116025050) according to the manufacturer’s 
protocol. Genomic DNA was removed from the samples using 
Turbo DNase (Ambion, catalogue number AM2238) with 4% 
v/v of RNAsecure RNase Inactivation Reagent (Ambion, cata-
logue number AM7005) added to each sample during DNase 
treatment to prevent RNA degradation. RNA was then purified 
using phenol-chloroform, with final elution in DEPC-treated 
water. Quality and concentration were checked by using a 2% 
agarose gel, and the Agilent 2100 Bioanalyzer RNA Nano 
protocol. Samples were then stored at -80°C until use. Extractions 
were performed in three biological replicates. RNA-seq was 
performed using an Illumina HiSeq 2000 sequencer, yielding 
9-23 million reads per library from 100 cycles of paired-end 
sequencing (Sequencing and mapping statistics are in Table S2, 
Extended data42). Sequence reads from each sample were 
mapped against the S. Typhimurium D23580 genome (Genbank 
accession number: FN424405). The reference was indexed, and 
the reads aligned using default parameters, with read trimming 
quality threshold set to 15 (q=15) and maximum insert size 
adjusted per library as the maximum requested fragment size 
of the sequencing library, implemented using BWA v0.7.1250. 
Expression values were computed from the read alignments 
to the coding sequence to generate the number of reads 
mapping51,52, including only reads with a mapping quality 
score of 10. Output spreadsheet files with features previously 
described53 were obtained for each sample. Total read counts for 
each gene in every sample were used, with zero values in the 
data thresholded to 1. Principal Component Analysis (PCA) plots 
of normalized counts were used to identify samples that did not 
cluster with their replicates, and one sample (run accession 
ERR731338) was excluded from subsequent analysis. Data 
normalization, filtering, and calculation of fold changes were 
performed using DESeq2 (v.1.4.5)54, and heatmaps and cluster 
dendrograms created using the heatmap.2 function of the gplots 
package (v.2.13.0), all implemented in R v.3.1.3.
Sequencing data accession number. The RNA-seq and 
PacBio data generated in this study were submitted to the 
European Nucleotide Archive, available under study accession 
number ERP005455.
Ethical approval. Ethical approval was from the College of 
Medicine Research and Ethics Committee, University of Malawi 
(Protocol Number P.05/06/388). Peripheral blood samples 
were obtained following written informed consent from each 
donor.
Results
S. Typhimurium isolates exhibit a stably inherited serum 
susceptibility phenotype. We have noted that even phylogeneti-
cally highly related ST313, that vary by only a few SNPs, can 
exhibit reproducible differences in their resistance to serum 
killing. Thus, in order to investigate this further we selected 
five isolates of lineage II (D23580, D24545, D23005, D25352, 
D24871) and two (A130 (a reference isolate), D26104) of line-
age I with different serum susceptibilities for detailed genotypic 
or phenotypic analysis. Two of these isolates, D23580 and 
D24871, were moderately susceptible to killing in normal serum. 
One isolate, D24545, was highly susceptible, while the other 
three had net growth after three hours of incubation in the same 
immune serum (Figure 1 A and B). To investigate if serum 
susceptibility was a stably inherited phenotype during culture, 
we performed serum killing assays on 100 independent 
colonies each of a serum resistant (D23005) and susceptible 
(D24545) isolate. No obvious differences in phenotype for either 
isolate was observed (Figure S1, Extended data42), therefore 
high frequency changes were considered unlikely to account for 
the observed variation in serum sensitivity.
Complete genome analysis of the iNTS isolates with different 
serum susceptibility. The genetic basis for variation in serum 
susceptibility between ST313 isolates is unknown. Therefore, to 
facilitate detailed genetic comparisons, we determined the 
complete genome sequence of each isolate using a combina-
tion of Illumina-generated short reads and PacBio long-read 
sequences55. No major alterations in chromosome arrange-
ment were apparent in any isolate using D23580 as the reference 
(Figure S2A (Extended data42) and 2B). For example, there 
were no large chromosomal inversions and no major deletions 
involving multiple or single genes. The traT and rck genes, two 
known serum resistance genes, were both intact and had 100% 
sequence identity in all the six isolates. Similarly, no difference, 
other than single SNPs were found in the 88kb p14-95A plasmid 
between D23580 and other isolates was observed (Figure 
S2C, Extended data42). Differences between ST313 clade I and 
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Figure 1. Characteristics of the six NTS isolates. A. Phylogenetic tree representing the relationships between the six NTS isolates studied. 
B. Fold change in bacterial counts following 3 hours of exposure to immune serum from a healthy adult donor. Each isolate was incubated 
at 37°C for 180 minutes with sampling at 45, 90 and 180 minutes. Data represent mean +/- standard error of two independent experiments, 
performed in triplicate.
isolates from clade II reflected lineage-specific genome evolution 
reported previously56 (Figure 1) (Figure S2, Extended data42). 
We therefore concluded that gene flux and major genome rear-
rangements do not obviously correlate with serum susceptibility 
phenotype.
To investigate whether nucleotide substitutions (SNPs) or small 
indels impact the degree of susceptibility to serum killing, 
SNPs in gene coding and promoter regions were analysed 
in five lineage II isolates with D23580 as the reference 
(Figure 1A). A total of 52 SNPs were identified (Table S3, 
Extended data42), confirming the high genetic similarity. Of 
these, 13 SNPs resulted in predicted nonsynonymous amino 
acid substitutions that were unique to either the highly sensitive 
(D24545) or one of two resistant isolates (D25352 and D23005) 
(Table 1).
We tested whether these individual nonsynonymous SNPs 
accounted for the altered serum susceptibility phenotype by intro-
ducing them into D23580. Three of the SNPs (in acrB, uxuR, 
and pepP) were specific to D24545 which is highly susceptible 
to serum killing and three were present in resistant isolates 
D25352 or D23005 (uxuB, ispD, and STMMW_29841). All of the 
recombinant D23580 derivatives exhibited similar sensitivity to 
wild type D23580 at all sampled time points, indicating that these 
polymorphisms had no detectable impact on serum susceptibility 
(Figure 2).
For functional analysis of the 52 SNPs occurring in clade II 
isolates, we compared RNA-seq and TraDIS data correspond-
ing to the regions where these SNPs occur. No significant 
changes, either in the viability of the corresponding transposon 
mutants or on the relative levels of transcription were observed 
(Table S3, Extended data42). D26104, a lineage I isolate, had 
significantly diminished expression of pgtE when compared 
to reference isolate D23580, consistent with lacking the pro-
moter mutation known to increase serum resistance in lineage II 
isolates20 (Table S8, Extended data42). Despite this, D26104 is a 
highly serum resistant isolate, suggesting an alternative mechanism 
of resistance in this isolate that is unlikely to be associated with 
the pgtE gene.
Identification of genes required for full serum resistance of 
S. Typhimurium D23580. By a complementary approach, we 
identified genes required for serum resistant ST313 using a whole 
genome functional screen with a saturating Tn5 transposon inser-
tion library in D23580. The number of Tn5 transposon insertion 
mutants in each gene before and after exposure to serum for 180 
minutes was determined by transposon directed insertion site 
sequencing (TraDIS). We classified genes as ‘serum resistance 
determinants’ if their disruption resulted in decreased viability in 
serum and therefore under-representation at the final timepoint. 
Under-representation was determined by a reduction in mapped 
read counts (relative to the library prior to serum exposure) 
of at least 2-fold and with an adjusted p-value of <0.05 or less. 
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Table 1. Polymorphisms occurring in clade II strains with atypical serum susceptibility. Only SNPs occurring in gene-coding regions 
and unique to each strain/phenotype are includeed. SNPs from acrB, pepP, ispD, uxu B, uxuR, and STMMW_29841 genes were transferred 
to D23580 and tested for their impact on resistance or sensitivity to serum killing by normal human serum.
Position 
in D23580
Systematic 
Gene ID
Gene 
name
Description D23580 base
SNP 
base
D24545 
(highly 
sensitive)
D23005 
(resistant)
D25352 
(resistant)
AA 
CHANGE
570516 STMMW_05451 acrB acriflavin resistance protein B C T T . . G796S
1200631 STMMW_11271 agp glucose-1-phosphatase precursor, secreted T C C . . L322P
1264174 STMMW_11931 rne ribonuclease E G T T . . R1062S
4277479 STMMW_40091 _ alcohol dehydrogenase T C C . . K78E
4390204 STMMW_41061 rpoB DNA-directed RNA polymerase, beta-subunit G A A . . D516N
4783703 STMMW_44531 uxuR uxu operon transcriptional regulator G A A . . W221STOP
3211805 STMMW_30181 pepP proline aminopeptidase II C A A . . E79D
3064062 STMMW_28931 ispD 2-C-methyl-D-erythritol4-phosphate cytidylyltransferase G T . T . R128W
3175291 STMMW_29841 _ probable amino acid transport protein T G . G . S255L
1947840 STMMW_18471 _ putative membrane protein T A . . A D181E
1875804 STMMW_17771 _ conserved hypothetical protein G A . . A R349W
1966357 STMMW_18691 pykA pyruvate kinase A G A . . A G124S
3289745 STMMW_30961 uxuB D-mannonate oxidoreductase A C . . C N361T
Figure 2. Relative serum sensitivity of D23580-derived strains with nonsynonymous polymorphisms transferred from serum resistant 
(D23005 and D25352) and susceptible (D24545) Salmonella Typhimurium strains. Each strain was exposed to immune human serum at 
37°C for 180 minutes with sampling at 45, 90 and 180 minutes. Squares represent strains with alleles from D24545, triangles from the resistant 
strains. Data represent means of two independent experiments, performed in triplicate. Error bars: Standard Error. HI control: Heat-inactivated 
control (Wild-type D23580 exposed to heat-inactivated serum).
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Similarly, we defined genes as ‘serum susceptibility deter-
minants’ if their disruption resulted in increased viability in 
serum and therefore over-representation at the final timepoint. 
We identified 555 serum resistance determinants and 82 serum 
susceptibility determinants (Complete results in Table S4, 
Extended data42).
To validate the transposon insertion library screen, we 
constructed defined mutations in D23580 by independently 
replacing 20 of the serum-resistance determinants with the aph 
gene conferring kanamycin resistance, by allelic exchange. The 
deleted genes were from a broad range of functional categories. 
Nine of the mutants tested (entD, osmC, uspF, wzzB, arnD, 
pmrD, wecA, cpxP and yjbE) had significantly increased suscepti-
bility to serum compared to wild–type D23580 (Figure 3).
Gene ontology (GO) terms associated with proteins encoded 
by serum-resistance determinants (Table S5) identified signifi-
cant enrichment of membrane components, particularly genes 
responsible for membrane and extracellular polysaccharides 
such as lipopolysaccharide (LPS) and enterobacterial common 
antigen (ECA) synthesis (33 genes) (Figure 4). Also, genes 
involved in iron transport, iron ion binding, or iron-sulfur cluster 
assembly binding were significantly represented (30 genes 
total), consistent with the iron-limiting conditions of serum 
contributing to diminished bacterial viability (Figure 4, Table S5 
(Extended data42)). 
Distinct transcriptional response is associated with serum 
susceptibility. To investigate whether variation in gene 
expression was associated with serum sensitivity in isolates with 
differential degrees of sensitivity, we analysed changes in 
transcription from bacteria exposed to normal human serum 
for 10 minutes relative to standard laboratory conditions (mid 
log culture in LB). This identified 170 genes as differentially 
expressed in all six isolates, 88 of which were up-regulated and 
82 down-regulated (Tables S6, S7). A significant proportion 
(49%) of the up-regulated genes included ones involved in iron 
scavenging and iron-associated metabolism, including fhu, ent, 
fep, suf, iro, exb, feo, and the sit operon (Table S6, Extended 
data42). The second most abundant group (12.5%) consisted of 
genes involved in colanic acid biosynthesis, including the rcsA 
regulator (Table S6, Extended data42). A majority of the 
down-regulated genes (55%) were associated with the bacterial 
envelope (Table S7, Extended data42). Notably, S. Typhimurium 
serum resistance genes rck, traT, and pgtE20, were not signifi-
cantly up-regulated in our experiments (Table S8, Extended 
data42).
We also identified transcriptional patterns that distinguished 
the isolates by serum susceptibility phenotype. Unsupervised 
clustering of the six S. Typhimurium strains based on the mag-
nitude of change in expression for all chromosomal genes 
revealed a pattern that approximately grouped the isolates by rela-
tive serum sensitivity (Figure 5A). The transcriptional response 
to serum killing of D26104 and D23005 that had the greatest 
resistance to serum killing were most similar to one another, 
D25352, D24871 and D23580 that were moderately resist-
ant or sensitive clustered, whilst the extremely susceptible strain 
D24545 had a distinct profile that was nonetheless most closely 
Figure 3. Susceptibility of D23580 mutants to the bactericidal activity of normal human serum relative to the wild-type strain. Bars 
show the mean log10 fold change +/- standard error of the mean in viable counts of twenty S. Typhimurium D23580 mutants following exposure 
to serum for 180 minutes. HIC: Heat-inactivated control (Wild-type D23580 exposed to heat-inactivated serum). P values above the bars 
represent t-test probabilities of pairwise comparisons of fold changes between each mutant strain and the wild-type strain.
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Figure 4. Significantly enriched gene ontology (GO) terms for 555 serum resistance-determining genes in D23580. Genes included in 
the analysis were those whose corresponding mutants had a fold change of 2-2 or lower from comparisons of input and output mutant libraries 
identified by TraDIS. P values are hypergeometric probabilities calculated using the phyper function in R. Comparisons were made using the 
number of genes associated with each term in the gene set versus the total number of genes associated with each term in the genome, using 
Salmonella Typhimurium LT2 GO annotation (http://www.uniprot.org/proteomes/UP000001014). Numbers within the bars represent the total 
number of genes in the essential gene set associated with each term.
related to other susceptible strains. Since both colanic acid and 
LPS polysaccharides are known to be associated with serum 
resistance in pathogenic Enterobacteria34,35,57 we investigated the 
transcriptional profile genes involved in their biosynthesis in the 
six strains (Figure 5B and C). A modest level of clustering of 
resistant and susceptible strains was also observed for genes 
involved in colanic acid biosynthesis and to a greater degree 
LPS biosynthesis. Notably, despite significant induction of a 
majority of the wca locus genes in all the strains (Table S6, 
Extended data42), elevation of transcription of these genes 
was higher in serum susceptible than serum resistant strains 
(Figure 5B).
We also identified genes that exhibited a significant difference 
in mean expression greater than 2-fold in the three resistant 
strains compared to the three susceptible strains, (p<0.05). A total 
of 45 genes had a ratio of 2 or more from comparison of means 
of either group, most of which are associated with putative or 
uncharacterized proteins (Figure 5D). Genes more highly 
expressed in response to serum in sensitive compared with 
resistant strains included yrbC, yiaD, which is a putative outer 
membrane (ompA) family protein, yibD, which is expressed in 
response to phosphate starvation, yggE, an oxidative response 
protein, heat shock protein hslJ, homeostasis protein cutC, 
lysozyme inhibitor mliC, flagellar biosynthetic protein fliR, 
metabolic proteins eutS, btuR, galU and odaA, cysZ transporter, 
yjbG, which increases resistance to bacitracin, and yaiW, a 
putative surface-exposed outer membrane lipoprotein. 12 genes 
were more highly up-regulated in response to serum in resistant 
compared with sensitive strains, and included glpB, porin protein 
ompD, hilD, a transcriptional regulator for multiple virulence 
genes, and bssR, which is induced in biofilms.
Notably, two LPS O-antigen genes, wzzB and fepE exhibited 
distinct responses to serum in resistant and susceptible strains. 
While the O-antigen polymerase wzzB was on average more 
highly up-regulated in serum-susceptible strains relative to 
serum-resistant ones, fepE, which modulates expression of very 
long O-antigen chains34, was on average 2-fold more highly 
expressed in serum-resistant strains than susceptible strains 
(Figure 5D).
Discussion
S. Typhimurium ST313 isolates that are highly resistant to serum 
killing have been identified raising the possibility that these 
may be the basis of escape mutants capable of evading vaccine- 
mediated antibody and complement killing. To better understand 
this problem, we investigated the molecular basis of resistance 
to antibody-mediated complement killing among iNTS iso-
lates. First, we analysed the genomic content of six bloodstream 
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Figure 5. Relative gene expression in six invasive Salmonella Typhimurium strains in response to serum exposure. Heat maps 
indicate log2 fold changes in transcript abundance following a 10-minute growth in serum compared to log-phase cultures in LB. Patterns 
of transcriptional responses are clustered and their relationship indicated by dendrograms. The intensities of each cell colour represent the 
deviation (Z-score) of each strain from the average fold change (centered to zero, represented with white on the heatmap) per gene for higher 
(red) or lower (blue), for all chromosomal genes (A), genes in the wca (colanic acid biosynthesis) locus (B), LPS biosynthesis genes (C), or 
genes satisfying a t-test cut-off of ≤0.05 and a ratio of ≥2 (D).
isolates with differing levels of resistance, to identify SNPs or 
larger modifications that may have an impact on serum resist-
ance. By this means, we were unable to find a basis for the 
differences in resistance.
TraDIS and transcriptomic profiling analyses revealed the reper-
toire of genes involved in survival and growth in serum in these 
S. Typhimurium ST313 isolates. Two major functional groups 
of differentially selected or expressed genes following serum 
exposure were identified: genes involved in nutrient scavenging, 
mainly the uptake and assimilation of iron, and genes involved 
in the synthesis of bacterial envelope components, particularly 
of extracellular polysaccharides. Several genes significantly 
up-regulated on exposure to serum, including ent, iro, sit, feo 
operons, tonB, exbB and exbD were essential for normal levels 
of viability in serum. For example, deletion of the entD gene 
in D23580 resulted in 40-fold lower viability than wild-type 
following 3 hours of exposure (Figure 3). Genes classically 
associated with serum resistance in S. Typhimurium, such as rck, 
traT, pgtE, however, were not significantly up-regulated at the 
time point investigated (Table S6, Extended data42). 
The bacterial membrane and its associated components are 
important for viability in serum. Whilst LPS genes were not 
significantly up-regulated during serum exposure, we did observe 
differences in expression patterns of LPS genes between 
the serum resistant and susceptible strains. In particular, the 
expression of O-antigen polymerase genes wzzB and the very 
long O-chain determinant fepE, were significantly different 
among these strains, with an average two-fold higher expres-
sion of fepE detectable within 10 minutes in resistant compared 
with susceptible strains as determined by RNAseq. Differences 
in the induction of these two genes resulting in preferential 
polymerization of LPS into trimodal (including very-long) rather 
than bimodal (with long) O-chain lengths confer resistance to 
antibody-dependent complement-mediated serum bactericidal 
activity in S. Typhimurium34.
Increased expression of wca locus genes, responsible for the 
synthesis of colanic acid exopolysaccharide was observed. 
Twenty genes comprise this operon in S. Typhimurium58, ten 
of which were differentially expressed in all six strains, along 
with rcsA, which regulates their expression. Rcs-associated 
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up-regulation of colanic acid genes in response to serum has 
been observed in pathogenic E. coli57,59, and is also induced by 
exposure to antimicrobial peptides in S. Typhimurium60. Expres-
sion of colanic acid is thought to mediate serum resistance 
either through formation of a barrier against lysis by the 
membrane attack complex57 or preventing complement activa-
tion by limiting access to LPS58. Although we found that colanic 
acid biosynthetic genes increased expression on exposure to 
serum, induction was greatest in susceptible strains. Further-
more, Tn5 insertions in colanic acid biosynthetic genes were not 
counter-selected in the TraDIS screen, and a null wcaB mutant 
was not more sensitive to antibody killing than the wild-type 
strain.
The relative lower induction of colanic acid biosynthetic gene 
in resistant strains may be linked to the higher increase in fepE 
expression in these strains. FepE is a positive regulator of very 
long LPS O-antigen chain associated with enhanced serum 
resistance34. In S. Typhi, fepE is a pseudo gene61, and very long 
LPS O-antigen chain interferes with the expression of the Vi 
exopolysaccharide capsule61. Lower expression of colanic acid 
biosynthesis genes may therefore facilitate the elaboration of 
very long LPS O-antigen chain and enhance serum resistance.
The large-scale genome-wide approaches used in this study 
provided a robust platform for investigating the full comple-
ment of genes necessary for survival of S. Typhimurium in 
serum. As with most high-throughput assay systems, some cave-
ats apply. For instance, with mutant libraries, it is not possi-
ble to distinguish between mutations associated with an overall 
decrease in bacterial viability or fitness over ones specifically 
necessary for complement resistance during selection in serum. 
Additionally, since the environmental signals ex vivo or in vitro 
are not identical to those in vivo, the information from the assays 
may not fully recapitulate the in vivo response to antibody- 
dependent complement killing. However, complementary results 
from the multiple approaches used in this study, mitigate these 
limitations to an extent.
We have defined gene functional classes and specific genes asso-
ciated with serum resistance in six S. Typhimurium bloodstream 
isolates. Investigation of the transcriptional response of resist-
ant and sensitive isolates highlighted putative factors respon-
sible for the diverse serum sensitivity phenotypes exhibited by 
isolates of S. Typhimurium ST313. While susceptibility to anti-
bodies was not associated with an identifiable genotype, distinct 
transcriptional responses were evident in resistant and sensi-
tive isolates, in particularly transcriptional response of genes 
associated with surface polysaccharides. It is hoped that this study 
will provide a basis for further research into modes of escape from 
natural and vaccine-induced immunity among invasive Salmonella 
strains.
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